Caffeine Citrate Injection, Solution
Product Images NDC 63323-407

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Caffeine Citrate (NDC 63323-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Caf02 0003 01)

Chemical formula: C14H18N4O5 Molecular weight: 386.31 g/mol This text provides information about the chemical formula and molecular weight of a compound.*

FDA Label Image

Logo (Caf02 0003 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

This is a description of a pharmaceutical product with NDC number 63323-407-03, containing Sterile, nonpyrogenic Caffeine Citrate for intravenous use. Each mL includes Caffeine citrate, caffeine anhydrous, citric acid, sodium citrate dihydrate, and water for injection. The product is for single use only and should be stored at 20° to 25°C. It is preservative-free and comes in a 3 mL Single Dose Vial. The container closure does not contain natural rubber latex.*

FDA Label Image

Ppackage Label (PRINCIPAL DISPLAY)

This text appears to be a medical description of a pharmaceutical product. It mentions details about a Caffeine Citrate Injection, USP, with specific dosage information and instructions for use. The product is labeled for single use only and is suitable for intravenous administration. It also provides storage recommendations and precautions about the container closure. Details about the manufacturer and the product's specifics are included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.